Akhondzadeh, Shahin

Clinical trial of adjunctive Celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

Akhondzadeh, S., Jafari, S., Raisi, F., Nasehi, A. A., Ghoreishi, A., Salehi, B., Mohebbi-Rasa, S., Raznahan, M., & Kamalipour, A. (2009) · Depression and Anxiety

Treatment of Major DepressionTryptophan and brain disorders

Cited by 397

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]

Akhondzadeh, S., Fallah-Pour, H., Afkham, K., Jamshidi, A.-H., & Khalighi-Cigaroudi, F. (2004) · BMC Complementary and Alternative Medicine

Saffron Plant Research StudiesMedicinal Plant Extracts Effects

Cited by 307

Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial

Akhondzadeh, S., Tahmacebi‐Pour, N., Noorbala, A., Amini, H., Fallah‐Pour, H., Jamshidi, A., & Khani, M. (2005) · Phytotherapy Research

Saffron Plant Research StudiesMedicinal Plant Extracts Effects

Cited by 298

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease

Akhondzadeh, S., Shafiee Sabet, M., Harirchian, M. H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S. S., Yousefi, M. H., Alimardani, R., Jamshidi, A., et al. (2010) · Psychopharmacology

Saffron Plant Research StudiesAlzheimer's disease research and treatments

Cited by 268

ORIGINAL ARTICLE: Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial: Saffron in the treatment of Alzheimer’s disease

Akhondzadeh, S., Sabet, M. S., Harirchian, M. H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S. S., Yousefi, M. H., Alimardani, R., Jamshidi, A., et al. (2010) · Journal of Clinical Pharmacy and Therapeutics

Saffron Plant Research StudiesAlzheimer's disease research and treatments

Cited by 249

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 155

Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial

Sepanjnia, K., Modabbernia, A., Ashrafi, M., Modabbernia, M.-J., & Akhondzadeh, S. (2012) · Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 153

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

Ghaleiha, A., Entezari, N., Modabbernia, A., Najand, B., Askari, N., Tabrizi, M., Ashrafi, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Journal of Psychiatric Research

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 152

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology

Ovarian function and disordersTreatment of Major Depression

Cited by 116

Prevalence of obsessive-compulsive disorder in Iran

Mohammadi, M. R., Ghanizadeh, A., Rahgozar, M., Noorbala, A. A., Davidian, H., Afzali, H. M., Naghavi, H. R., Yazdi, S. A. B., Saberi, S. M., Mesgarpour, B., et al. (2004) · BMC Psychiatry

Obsessive-Compulsive Spectrum DisordersMental Health Treatment and Access

Cited by 113

Crocus sativus L. versus citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trial

Ghajar, A., Neishabouri, S., Velayati, N., Jahangard, L., Matinnia, N., Haghighi, M., Ghaleiha, A., Afarideh, M., Salimi, S., Meysamie, A., et al. (2017) · Pharmacopsychiatry

Saffron Plant Research StudiesTreatment of Major Depression

Cited by 110

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

Khodaie-Ardakani, M.-R., Mirshafiee, O., Farokhnia, M., Tajdini, M., Hosseini, S.-M.-R., Modabbernia, A., Rezaei, F., Salehi, B., Yekehtaz, H., Ashrafi, M., et al. (2014) · Psychiatry Research

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 104

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder

Kahbazi, M., Ghoreishi, A., Rahiminejad, F., Mohammadi, M.-R., Kamalipour, A., & Akhondzadeh, S. (2009) · Psychiatry Research

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 91

Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial

Arabzadeh, S., Hakkikazazi, E., Shahmansouri, N., Tafakhori, A., Ghajar, A., Jafarinia, M., & Akhondzadeh, S. (2018) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 89

Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial

Salehi, B., Imani, R., Mohammadi, M. R., Fallah, J., Mohammadi, M., Ghanizadeh, A., Tasviechi, A. A., Vossoughi, A., Rezazadeh, S.-A., & Akhondzadeh, S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Attention Deficit Hyperactivity DisorderGinkgo biloba and Cashew Applications

Cited by 89

Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial

Amiri, S., Mohammadi, M.-R., Mohammadi, M., Nouroozinejad, G.-H., Kahbazi, M., & Akhondzadeh, S. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 82

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial

Gougol, A., Zareh-Mohammadi, N., Raheb, S., Farokhnia, M., Salimi, S., Iranpour, N., Yekehtaz, H., & Akhondzadeh, S. (2015) · Journal of Psychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 77

The role of phthalate esters in autism development: A systematic review

Jeddi, M. Z., Janani, L., Memari, A. H., Akhondzadeh, S., & yunesian, M. (2016) · Environmental Research

Effects and risks of endocrine disrupting chemicalsAutism Spectrum Disorder Research

Cited by 76

Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: a double-blind, placebo-controlled, randomized trial

Abbasi, S. H., Mohammadinejad, P., Shahmansouri, N., Salehiomran, A., Beglar, A. A., Zeinoddini, A., Forghani, S., & Akhondzadeh, S. (2015) · Journal of Affective Disorders

Treatment of Major DepressionLipoproteins and Cardiovascular Health

Cited by 70

Aspirin for treatment of lithium‐associated sexual dysfunction in men: randomized double‐blind placebo‐controlled study

Saroukhani, S., Emami‐Parsa, M., Modabbernia, A., Ashrafi, M., Farokhnia, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Bipolar Disorders

Sexual function and dysfunction studiesBipolar Disorder and Treatment

Cited by 59

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder

Heidari, M., Zarei, M., Hosseini, S. M. R., Taghvaei, R., Maleki, H., Tabrizi, M., Fallah, J., & Akhondzadeh, S. (2014) · International Clinical Psychopharmacology

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 48

Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study

Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S. H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M.-R., Shahmirzadi, M., et al. (2019) · Journal of Child and Adolescent Psychopharmacology

Saffron Plant Research StudiesAttention Deficit Hyperactivity Disorder

Cited by 46

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial

Zarinara, A., Mohammadi, M., Hazrati, N., Tabrizi, M., Rezazadeh, S., Rezaie, F., & Akhondzadeh, S. (2010) · Human Psychopharmacology: Clinical and Experimental

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 44

Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial

Alamdarsaravi, M., Ghajar, A., Noorbala, A.-A., Arbabi, M., Emami, A., Shahei, F., Mirzania, M., Jafarinia, M., Afarideh, M., & Akhondzadeh, S. (2017) · Psychiatry Research

Treatment of Major DepressionCancer survivorship and care

Cited by 43